Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Geoff Duyk
Overview
- Gender
- male
Dr. Duyk is a former board member and President of Research & Development at Exelixis Inc. (NASDAQ: EXEL). Previously, Dr. Duyk was one of the founding scientific staff at Millennium Pharmaceuticals Inc. (now Millennium: The Takeda Oncology Company) and served as Vice President of Genomics at Millennium Pharmaceuticals Inc. He also was an Assistant Professor at Harvard Medical School and Assistant Investigator of the Howard Hughes Medical Institute. Dr. Duyk is a member of the Board of Directors of the American Society of Human Genetics.
Jobs
Number of Current Jobs
1
Geoff Duyk has 1 current jobs including
Board of Director at Epirus Biopharmaceuticals
,
.
| Organization Name | Title At Company | Start Date | End Date | |
|---|---|---|---|---|
Epirus Biopharmaceuticals
|
Board of Director | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
